OTTAVA WEEKEND
top of page

Are you struggling with your surgical robot? Are you finding challenges with your complex medical device? Need external experts to take a look and help you? Team Purple has you covered...

 

​​​​

Search

OTTAVA WEEKEND

All my speculations and articles on what we know so far about Johnson & Johnson's table based OTTAVA soft tissue surgical robot.


Ottava - all the details we know about it in one place
Ottava Soft Tissue Surgical Robot

Early review from last year that explores the architecture of Ottava and what could be the pros and cons of a table mounted robot

Different architectures of arms for surgical robots and where Ottava fits in

From the public documents in the Auris case vs JNJ what can we learn about Ottava and why it has become the deign it has

Deep dive into the different architectures of surgical robots and how it changes how they work

Dualto - has many design cues and software clues that link to Ottava patents and tower patents - does it give us deeper clues as to how the tower of Ottava may be organised

Patent searches on recently updated patents may give some key clues to how you use Ottava in the real world

The Ethicon 4000 stapler - claimed to be ready for Ottava integration - here's what we know

A core part of an Ottava system is the tower - this post uses the Ottava tower patents to recreate what the Ottava tower my be made up of and why

(Of course my scouse humour was to put this in a table... get it...)


Ottava seems to be an exciting third alternative to Intuitive Boom designs, and Medtronic modular designs. I've pulled together everything publically known about Ottava and presented it here in this series of blog post. Keep reminding yourself that this is only speculation as much of the details of Ottava has been kept a deep secret.


However we do know it is currently in IDE trials for Bariatrics - cases are recruiting and JNJ has indicated a 2026 submission for FDA in the USA. Browsing job offerings and recruitment - it is clear that JNJ is preparing critical markets like the USA, Europe and especially Japan for an early commercial push of this technology.


These are simply speculations and opinions of the author for education purposes only - based on publicly available information.

Get the Ultimate Medtech Survival Guide now

Copyright & Fair Use Notice

All content on this website is the copyright of Steve Bell S.R.L. and remains the proprietary property of the authors. This site utilizes third-party media in good faith for educational commentary and transformative analysis under Fair Use provisions.

1. Mandatory Notice and Takedown: I respect intellectual property. If you believe any material is used outside of fair use, your sole and exclusive remedy is to contact steve@howtostartupinmedtech.com for immediate removal. I will act promptly on any reasonable request.

2. Prohibition of Automated Enforcement: I explicitly prohibit the use of automated "copyright enforcement" bots (including but not limited to PicRights, Copytrack, Pixsy, AP, or Reuters bots) to scrape this site for speculative invoicing.

3. GDPR & Contractual Agreement: By bypassing technical headers (robots.txt) or scraping this site, you (the "Scraper") enter into a binding legal contract with Steve Bell S.R.L. You acknowledge that this site contains my Personally Identifiable Information (PII) and personal likeness. As a result:

You are legally deemed a Data Processor under EU GDPR.

Any automated claim sent to Steve Bell S.R.L. or Steve Bell  must be accompanied by a full Article 15 Disclosure Report detailing exactly how my PII was processed and whether it was transferred outside the EEA.

Failure to provide this report or bypassing my technical blocks will be reported to the Italian Data Protection Authority (Garante per la protezione dei dati personali) as a breach of privacy law.

​

Anti-Scraping & Automated Enforcement Clause

​Contractual Agreement: By bypassing technical headers (robots.txt) or scraping this site to generate a claim, you (the Scraper) explicitly enter into a binding contract with Steve Bell S.R.L. You agree to waive all automated "settlement" fees in favor of the Notice and Takedown protocol above.

Reinforced statement: GDPR & International Data Transfer: This site contains my personal likeness and identifiable data (PII). Any entity scraping this data becomes a Data Processor under EU law. Any automated claim must be accompanied by a full GDPR Article 15 report detailing where my PII is stored and confirming compliance with international data transfer regulations (EEA to non-EEA). Unauthorized processing will be reported to the Garante per la protezione dei dati personali.

​

Notice to scraping services: Please read the scraping policy 

How to start a medtech company

©2023-2026 by How to Startup in MedTech 

Steve Bell S.R.L. (unipersonale) – Sede legale: Via Nalles 95, 00124 Roma (RM)  Italy

P.IVA / C.F. 18199441009  – REA RM- 1768831  – Cap. Soc. €10.000 i.v. – PEC: stevebellsrl@pec.it

bottom of page